{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T18:53:12Z","timestamp":1794077592576,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PO1 AI120944"],"award-info":[{"award-number":["PO1 AI120944"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5U19AI172713"],"award-info":[{"award-number":["5U19AI172713"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI077821"],"award-info":[{"award-number":["U01 AI077821"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI135947"],"award-info":[{"award-number":["U01 AI135947"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5K23AI139335"],"award-info":[{"award-number":["5K23AI139335"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016206","name":"University of California Los Angeles Clinical and Translational Science Institute","doi-asserted-by":"publisher","award":["UL1TR001881"],"award-info":[{"award-number":["UL1TR001881"]}],"id":[{"id":"10.13039\/100016206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001259","name":"National Kidney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001721","name":"Koch Foundation","doi-asserted-by":"publisher","award":["R01AI173050"],"award-info":[{"award-number":["R01AI173050"]}],"id":[{"id":"10.13039\/100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001721","name":"Koch Foundation","doi-asserted-by":"publisher","award":["R01AI135201"],"award-info":[{"award-number":["R01AI135201"]}],"id":[{"id":"10.13039\/100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001463","name":"American Society of Nephrology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ajt.2025.07.2486","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:37:22Z","timestamp":1754437042000},"page":"2329-2344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antibodies to angiotensin II type 1 receptor and endothelin type A receptor are associated with cytokine production enriched for type 2 immune response and antibody production in pediatric kidney transplant recipients"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6070-4793","authenticated-orcid":false,"given":"Meghan H.","family":"Pearl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-4209","authenticated-orcid":false,"given":"Lucia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9471-2938","authenticated-orcid":false,"given":"Tristan","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6749-7713","authenticated-orcid":false,"given":"Niloufar","family":"Nikfarjam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-8592","authenticated-orcid":false,"given":"Paul C.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1866-3964","authenticated-orcid":false,"given":"Chris","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2936-3676","authenticated-orcid":false,"given":"Rouba","family":"Garro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7060-9311","authenticated-orcid":false,"given":"Eileen","family":"Tsai-Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2004-5962","authenticated-orcid":false,"given":"Allan D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9973-7349","authenticated-orcid":false,"given":"Robert","family":"Ettenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-545X","authenticated-orcid":false,"given":"Elaine F.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajt.2025.07.2486_bib1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrneph.2016.88","article-title":"The importance of non-HLA antibodies in transplantation","volume":"12","author":"Zhang","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.ajt.2025.07.2486_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.kint.2016.03.019","article-title":"Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity","volume":"90","author":"Dragun","year":"2016","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ajt.2025.07.2486_bib3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfab344","article-title":"Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis","volume":"37","author":"Kang","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2025.07.2486_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajt.2025.07.2486_bib5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.kint.2017.06.034","article-title":"Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation","volume":"93","author":"Pearl","year":"2018","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ajt.2025.07.2486_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/ndt\/gfy008","article-title":"Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients","volume":"33","author":"Fichtner","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2025.07.2486_bib7","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s00467-021-04969-1","article-title":"Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients","volume":"36","author":"Fichtner","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.ajt.2025.07.2486_bib8","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.07.2486_bib9","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/ndt\/gfw204","article-title":"Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies","volume":"31","author":"Cuevas","year":"2016","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"10.1016\/j.ajt.2025.07.2486_bib10","first-page":"218","article-title":"Pre-transplant angiotensin II type 1receptor antibodies: a risk factor for decreased kidney graft function in the early post-transplant period?","volume":"66","author":"Hern\u00e1ndez-M\u00e9ndez","year":"2014","journal-title":"Rev Invest Clin"},{"issue":"3","key":"10.1016\/j.ajt.2025.07.2486_bib11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/TP.0000000000001231","article-title":"Anti-angiotensin II type 1 receptor and anti-endothelial cell antibodies: a cross-sectional analysis of pathological findings in allograft biopsies","volume":"101","author":"Philogene","year":"2017","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.ajt.2025.07.2486_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14400","article-title":"Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: an observational cohort study","volume":"26","author":"Pizzo","year":"2022","journal-title":"Pediatr Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2025.07.2486_bib13","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/tri.13009","article-title":"Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study","volume":"30","author":"Deltombe","year":"2017","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.ajt.2025.07.2486_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trim.2013.10.007","article-title":"The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes","volume":"30","author":"Banasik","year":"2014","journal-title":"Transpl Immunol"},{"issue":"11","key":"10.1016\/j.ajt.2025.07.2486_bib15","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ekir.2020.09.004","article-title":"Endothelin type A receptor antibodies are associated with angiotensin II type 1 receptor antibodies, vascular inflammation, and decline in renal function in pediatric kidney transplantation","volume":"5","author":"Pearl","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.ajt.2025.07.2486_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/TP.0000000000004753","article-title":"Non-HLA antibodies to G protein-coupled receptors in pediatric kidney transplant recipients: short- and long-term clinical outcomes","volume":"108","author":"Pearl","year":"2024","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.ajt.2025.07.2486_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/petr.12531","article-title":"De novo development of antibodies to kidney-associated self-antigens angiotensin II receptor type I, collagen IV, and fibronectin occurs at early time points after kidney transplantation in children","volume":"19","author":"Hesemann","year":"2015","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2025.07.2486_bib18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/petr.12728","article-title":"Angiotensin II type 1 receptor antibodies in childhood kidney transplantation","volume":"20","author":"Bjerre","year":"2016","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.07.2486_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ekir.2018.12.011","article-title":"Cytokine profiles associated with angiotensin II type 1 receptor antibodies","volume":"4","author":"Pearl","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.ajt.2025.07.2486_bib20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/ajt.14169","article-title":"Relationship among viremia\/viral infection, alloimmunity, and nutritional parameters in the first year after pediatric kidney transplantation","volume":"17","author":"Ettenger","year":"2017","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.07.2486_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ajt.2025.07.2486_bib22","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.kint.2020.10.047","article-title":"Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease","volume":"99","author":"Pierce","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ajt.2025.07.2486_bib23","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/TP.0000000000001389","article-title":"A 3-center study reveals new insights into the impact of non-HLA antibodies on lung transplantation outcome","volume":"101","author":"Reinsmoen","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2025.07.2486_bib24","series-title":"SAS for Mixed Models","first-page":"814","author":"Littell","year":"2006"},{"key":"10.1016\/j.ajt.2025.07.2486_bib25","series-title":"Applied Longitudinal Analysis","first-page":"701","author":"Fitzmaurice","year":"2011"},{"issue":"11","key":"10.1016\/j.ajt.2025.07.2486_bib26","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.ajt.2025.07.2486_bib27","author":"Burel"},{"issue":"5","key":"10.1016\/j.ajt.2025.07.2486_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri3824","article-title":"The development and in vivo function of T helper 9 cells","volume":"15","author":"Kaplan","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.ajt.2025.07.2486_bib29","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/HYPERTENSIONAHA.122.18657","article-title":"Ang II (Angiotensin II)-induced FGFR1 (fibroblast growth factor receptor 1) activation in tubular epithelial cells promotes hypertensive kidney fibrosis and injury","volume":"79","author":"Xu","year":"2022","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ajt.2025.07.2486_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/carcin\/bgh324","article-title":"Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth","volume":"26","author":"Fujita","year":"2005","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.ajt.2025.07.2486_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14851","article-title":"Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment","volume":"37","author":"Lion","year":"2023","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2025.07.2486_bib32","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.1201434","article-title":"HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging Fc\u03b3Rs","volume":"190","author":"Valenzuela","year":"2013","journal-title":"J Immunol."},{"key":"10.1016\/j.ajt.2025.07.2486_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1289744","article-title":"Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-\u03b1 signaling","volume":"14","author":"Moll","year":"2023","journal-title":"Front Immunol"},{"issue":"22","key":"10.1016\/j.ajt.2025.07.2486_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213829","article-title":"Multiplex analysis of serum cytokine profiles in systemic lupus erythematosus and multiple sclerosis","volume":"23","author":"Melamud","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ajt.2025.07.2486_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/TP.0000000000001452","article-title":"Interleukin-6, a cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade","volume":"101","author":"Jordan","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2025.07.2486_bib36","article-title":"Endothelin-A receptor antagonist alleviates allergic airway inflammation via the inhibition of ILC2 function","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ajt.2025.07.2486_bib37","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211001","article-title":"Angiotensin II enhances group 2 innate lymphoid cell responses via AT1a during airway inflammation","volume":"219","author":"Liu","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajt.2025.07.2486_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.945063","article-title":"Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis","volume":"13","author":"Kokubo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2025.07.2486_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688647","article-title":"The roles of kidney-resident ILC2 in renal inflammation and fibrosis","volume":"12","author":"Nagashima","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2025.07.2486_bib40","article-title":"Interleukin-33\/suppression of tumorigenicity 2 in renal fibrosis: emerging roles in prognosis and treatment","volume":"12","author":"Tan","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajt.2025.07.2486_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gene.2017.11.010","article-title":"Interleukin-33 levels are elevated in chronic allograft dysfunction of kidney transplant recipients and promotes epithelial to mesenchymal transition of human kidney (HK-2) cells","volume":"644","author":"Xu","year":"2018","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.ajt.2025.07.2486_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112705","article-title":"Role of the IL-33\/ST2 pathway in renal allograft rejection","volume":"405","author":"Yu","year":"2021","journal-title":"Exp Cell Res"},{"issue":"4","key":"10.1016\/j.ajt.2025.07.2486_bib43","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/hr.2012.196","article-title":"All-Literature Investigation of Cardiovascular Evidence Group. Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials","volume":"36","author":"Takagi","year":"2013","journal-title":"Hypertens Res"},{"issue":"3","key":"10.1016\/j.ajt.2025.07.2486_bib44","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/ijms23031772","article-title":"Immunomodulatory activity of the most commonly used antihypertensive drugs-angiotensin converting enzyme inhibitors and angiotensin II receptor blockers","volume":"23","author":"Bryniarski","year":"2022","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.ajt.2025.07.2486_bib45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bcp.2016.07.008","article-title":"TNF\u03b1-induced airway smooth muscle cell proliferation depends on endothelin receptor signaling, GM-CSF and IL-6","volume":"116","author":"Knobloch","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajt.2025.07.2486_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1218082","article-title":"Engineering cytokines for cancer immunotherapy: a systematic review","volume":"14","author":"Fu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2025.07.2486_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152740","article-title":"Personalised treatment of rheumatoid arthritis based on cytokine profiles and synovial tissue signatures: potentials and challenges","volume":"73","author":"Avouac","year":"2025","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.ajt.2025.07.2486_bib48","article-title":"Pro-inflammatory cytokines in myasthenia gravis: a systematic review and meta-analysis","volume":"10","author":"Shushtari","year":"2025","journal-title":"Neurol Sci"},{"issue":"375","key":"10.1016\/j.ajt.2025.07.2486_bib49","article-title":"Th9-derived IL-9 in autoimmune diseases: an update","volume":"17","author":"Chen","year":"2025","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.ajt.2025.07.2486_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-022-00557-6","article-title":"Emerging principles of cytokine pharmacology and therapeutics","volume":"22","author":"Saxton","year":"2023","journal-title":"Nat Rev Drug Discov."},{"issue":"3","key":"10.1016\/j.ajt.2025.07.2486_bib51","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.kint.2021.09.029","article-title":"Non-HLA antibodies targeting angiotensin II type 1 receptor and endothelin-1 type A receptors induce endothelial injury via \u03b22-arrestin link to mTOR pathway","volume":"101","author":"Catar","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajt.2025.07.2486_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/frtra.2023.1273890","article-title":"Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy","volume":"2","author":"Philippe","year":"2023","journal-title":"Front Transplant"}],"updated-by":[{"DOI":"10.1016\/j.ajt.2025.11.019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000}},{"DOI":"10.1016\/j.ajt.2025.11.019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000}}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525028771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525028771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:33:47Z","timestamp":1778823227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525028771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1600613525028771"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.07.2486","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies to angiotensin II type 1 receptor and endothelin type A receptor are associated with cytokine production enriched for type 2 immune response and antibody production in pediatric kidney transplant recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.07.2486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}